SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-263197
Filing Date
2020-10-05
Accepted
2020-10-05 06:06:54
Documents
15
Period of Report
2020-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d15849d8k.htm   iXBRL 8-K 28491
2 EX-1.1 d15849dex11.htm EX-1.1 245674
3 EX-5.1 d15849dex51.htm EX-5.1 4945
7 GRAPHIC g15849img01.jpg GRAPHIC 12931
  Complete submission text file 0001193125-20-263197.txt   490045

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA logc-20201001.xsd EX-101.SCH 3069
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20201001_lab.xml EX-101.LAB 18887
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20201001_pre.xml EX-101.PRE 11859
8 EXTRACTED XBRL INSTANCE DOCUMENT d15849d8k_htm.xml XML 3477
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 201222237
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences